Young blood - it's not quite the fountain of youth to reverse aging, but there are some benefits worth exploring...

Ambrosia, the start-up from Silicon Valley selling blood plasma for transfusions from the young promised to reverse aging for all of us. However, they have since run into issues with the US FDA regulators.
We also have Alkahest, founded by Professor Tony Wyss-Coray with a transparent approach in identifying key proteins from blood plasma linked to aging and trying to manipulate these to reduce age-related diseases.
Let's find out how well these very distinct approaches will age with time...

Follow me on Twitter and Instagram @BioTechBasics:
[ Ссылка ]
[ Ссылка ]

Music:
DeeTunez - Ocean
[ Ссылка ]

References:
Brief summary on the studies demonstrating young blood rejuvenating old mice: [ Ссылка ]
Initial study highlighting the regenerative potential of heterochronic parabiosis in mice (2005):
[ Ссылка ]
Insight to Ambrosia and its end: [ Ссылка ]
Unveil of Ambrosia clinics in 5 US cities:
[ Ссылка ]
FDA press statement on young blood transfusions: [ Ссылка ]
Profile on Alkahest - [ Ссылка ]
Alkahest phase II clinical trial [ Ссылка ]
Grifols equity investment into Alkahest press release: [ Ссылка ]

Medlife Crisis have a good video on this: [ Ссылка ]

свернуть